Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction

The Prospective comparison of Angiotensin Receptor-neprilysin inhibitor (ARNI) with Angiotensin converting enzyme inhibitor (ACEI) to Determine Impact on Global Mortality and morbidity in Heart Failure (HF) trial (PARADIGM-HF) showed that adding a neprilysin inhibitor (sacubitril) to a renin-angiote...

Descripción completa

Detalles Bibliográficos
Autores principales: Dewan, Pooja, Docherty, Kieran F., McMurray, John J.V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554586/
https://www.ncbi.nlm.nih.gov/pubmed/31172710
http://dx.doi.org/10.4070/kcj.2019.0136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554586/
https://www.ncbi.nlm.nih.gov/pubmed/31172710
http://dx.doi.org/10.4070/kcj.2019.0136

Ejemplares similares